1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with angiotensin ii in 55 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (angiotensin ii) | Trials (angiotensin ii) | Recent Studies (post-2010) (angiotensin ii) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 38,152 | 1,089 | 7,413 |
Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | angiotensin ii (IC50) |
---|---|---|---|
Atrial natriuretic peptide receptor 3 | Homo sapiens (human) | 0.002 | |
Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.002 | |
Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0018 | |
Type-1 angiotensin II receptor | Homo sapiens (human) | 0.0055 | |
Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.004 | |
Type-2 angiotensin II receptor | Homo sapiens (human) | 0.0011 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 24 (43.64) | 18.7374 |
1990's | 26 (47.27) | 18.2507 |
2000's | 5 (9.09) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, PJ; Crawley, DE; Evans, TW; McCormack, DG | 1 |
Babycos, CR; Hood, JS; Ibrahim, IN; Kadowitz, PJ; McMahon, TJ; Nossaman, BD; Ragheb, MS | 1 |
Andrade, SP; Bakhle, YS; Piper, PJ; Vieira, LB | 2 |
Andrade, SP; Bakhle, YS; Hart, I; Piper, PJ | 1 |
Chang, SW; Chen, CR; Voelkel, NF | 1 |
Furman, BL; Gray, GA; Parratt, JR | 1 |
Brandt, R; Kanowski, U; Kempfert, C; Oddoy, A; Siewert, B | 1 |
Alessi, D; Bussolino, F; Camussi, G; Turello, E | 1 |
Boudreau, N; Rabinovitch, M; Turner-Gomes, SO | 1 |
Chambaz, EM; Keramidas, M; Pelosin, JM | 1 |
Barden, A; Nies, AS; Sturm, M; Tunney, A; Vandongen, R | 1 |
Bernabeu, F; Gómez-Garre, D; López-Farré, A; López-Novoa, JM; Millás, I; Montañés, I | 1 |
Kawaguchi, H; Sawa, H; Yasuda, H | 1 |
Iizuka, K; Kawaguchi, H; Sawa, H; Yasuda, H | 1 |
Dunlop, ME; Larkins, RG | 1 |
DeCandido, S; Hassid, A; Satriano, JA; Schlondorff, D; Singhal, P | 1 |
Clay, K; DeCandido, S; Neuwirth, R; Satriano, JA; Schlondorff, D | 1 |
Gerkens, JF | 1 |
Atkinson, PM; Hofmeyr, GJ; Rodrigues, FA; Sonnendecker, EW | 1 |
Felsen, D; Freund, RM; Vaughan, ED; Weisman, SM | 1 |
Hackenthal, E; Taugner, R | 1 |
Barrio, V; De Arriba, G; López-Novoa, JM; Rodríguez-Puyol, D | 1 |
Haslam, RJ; Vanderwel, M | 1 |
Hassid, A; Kreisberg, JI | 1 |
Chang, SW; Henson, PM; McMurtry, IF; Pfeffer, KD; Voelkel, NF; Worthen, SG | 1 |
DeCandido, S; Satriano, JA; Schlondorff, D | 1 |
Chang, SW; Haynes, J; Morris, KG; Voelkel, NF | 1 |
Schwertschlag, US; Whorton, AR | 1 |
Gerber, JG; Mathias, M; Nies, AS; Scherf, H; Schwertschlag, U | 1 |
Brooks, B; Muirhead, EE; Pitcock, JA | 1 |
Kawaguchi, H; Yasuda, H | 1 |
Braquet, P; Hebert, RL; Lamoureux, C; Plante, GE; Sirois, P | 1 |
Ardaillou, N; Ardaillou, R; Hagege, J; Nivez, MP; Schlondorff, D | 1 |
Bowdy, BD; Gillespie, MN | 1 |
Cervoni, P; Goldstein, BM; Herzlinger, H; Lai, FM; Quirk, GJ | 1 |
Koyama, Y; Kumahara, Y; Masugi, F; Ogihara, T; Otsuka, A; Saeki, S | 1 |
Aglietta, M; Bussolino, F; Camussi, G; Malavasi, F; Piacibello, W; Sanavio, F; Tetta, C | 1 |
Corvera, S; García-Sáinz, JA; Mendlovic, F | 1 |
Baum, T; Eynon, E; Moran, R; Nelson, S; Sabin, C; Sybertz, EJ | 1 |
Buckalew, VM; Handa, RK; Strandhoy, JW | 1 |
Arakawa, T; Inishi, Y; Kurokawa, K; Ohara, M; Okuda, T; Yasuda, C | 1 |
Arakawa, T; Inishi, Y; Kurokawa, K; Okuda, T | 1 |
Krämer, K; Markwitan, A; Pallauf, J | 1 |
Dahms, TE; Ohar, JA; Waller, KS | 1 |
Handa, RK; Strandhoy, JW | 1 |
Arai, Y; Asano, M; Honda, K; Inagaki, O; Kasai-Nakagawa, C; Takanashi, M; Takenaka, T; Takizawa, K; Tanaka, A; Uchida, W; Yatsu, T | 1 |
Aiello, S; Konopka, K; Lapinski, R; Noris, M; Perico, N; Remuzzi, G | 1 |
Hibler, S; Ibe, BO; Raj, JU | 1 |
Biancone, L; Bussolati, B; Cambi, V; Camussi, G; David, S; Foà, R; Mariano, F | 1 |
Alvarez, A; Sanz, MJ | 1 |
Akamine, E; Carvalho, MH; Fortes, ZB; Nigro, D; Passaglia, RC; Toledo, DP | 1 |
Blázquez, MA; Cerdá-Nicolás, M; Cortijo, J; Estellés, R; Issekutz, AC; Ivorra, MD; Losada, M; Mateo, T; Milian, L; Morcillo, EJ; Nabah, YN; Sanz, MJ | 1 |
Chong, T; Ramirez, R; Victorino, GP | 1 |
Frey, M; Herndon, DH; Jeschke, MG; Kamolz, LP; Keck, M | 1 |
4 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and angiotensin ii
Article | Year |
---|---|
Hormonal signals and intracellular messengers for renin secretion.
Topics: Acetylcholine; Adenosine; Adenylyl Cyclases; Adrenergic alpha-Agonists; Angiotensin II; Animals; Atrial Natriuretic Factor; Calcium; Cyclic AMP; Cyclic GMP; Dopamine; Epinephrine; Histamine; Hormones; Nerve Tissue Proteins; Neuropeptide Y; Norepinephrine; Platelet Activating Factor; Prostaglandins; Renin; Vasopressins | 1986 |
Functional properties of glomerular cells in culture.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Calcium; Cell Adhesion; Cells, Cultured; Contractile Proteins; Cyclic AMP; Diabetes Mellitus; Dinoprostone; Epithelial Cells; Glomerular Mesangium; Glomerulonephritis; Humans; Kidney Glomerulus; Platelet Activating Factor; Prostaglandins; Prostaglandins E; Rats | 1986 |
Renal medullary system of blood pressure control.
Topics: Angiotensin II; Animals; Blood Pressure; Heart Rate; Hypertension, Renovascular; Kidney Medulla; Methylamines; Platelet Activating Factor; Rats; Renin-Angiotensin System | 1986 |
Pathophysiology of burns.
Topics: Angiotensin II; Animals; Burns; Catecholamines; Edema; Hemodynamics; Histamine; Humans; Hypovolemia; Inflammation Mediators; Platelet Activating Factor; Prostaglandins; Serotonin; Skin; Soft Tissue Injuries; Thromboxanes; Vascular Resistance; Vasopressins | 2009 |
51 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and angiotensin ii
Article | Year |
---|---|
Bleomycin-induced lung injury in rats selectively abolishes hypoxic pulmonary vasoconstriction: evidence against a role for platelet-activating factor.
Topics: Acetylcholine; Angiotensin II; Animals; Bleomycin; Blood Pressure; Constriction, Pathologic; Hypoxia; In Vitro Techniques; Male; Platelet Activating Factor; Pulmonary Artery; Rats; Rats, Inbred Strains; Respiratory Distress Syndrome; Vasodilation | 1992 |
Blockade of thromboxane/endoperoxide receptor-mediated responses in the pulmonary vascular bed of the cat by sulotroban.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Angiotensin II; Animals; Arachidonic Acid; Blood Pressure; Cats; Endothelins; Female; Histamine; Lung; Male; Norepinephrine; Platelet Activating Factor; Prostaglandin Endoperoxides, Synthetic; Prostaglandins; Receptors, Prostaglandin; Receptors, Thromboxane; Serotonin; Sulfonamides | 1992 |
Effects of platelet activating factor (PAF) and other vasoconstrictors on a model of angiogenesis in the mouse.
Topics: Angiotensin II; Animals; Endothelins; Granulation Tissue; Male; Mice; Mice, Inbred BALB C; Models, Biological; Neovascularization, Pathologic; Platelet Activating Factor; Prostheses and Implants; Regional Blood Flow; Skin; Xenon Radioisotopes | 1992 |
Effects of tumour cells on angiogenesis and vasoconstrictor responses in sponge implants in mice.
Topics: Adenocarcinoma; Angiotensin II; Animals; Blood Vessels; Colonic Neoplasms; Endothelins; Epinephrine; Half-Life; Male; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neovascularization, Pathologic; Platelet Activating Factor; Polyurethanes; Prostheses and Implants; Serotonin; Tumor Cells, Cultured; Vasoconstrictor Agents; Xenon Radioisotopes | 1992 |
Pulmonary vascular reactivity: effect of PAF and PAF antagonists.
Topics: Angiotensin II; Animals; Azepines; Hypoxia; In Vitro Techniques; Male; Phospholipid Ethers; Platelet Activating Factor; Pulmonary Circulation; Pulmonary Edema; Quinolinium Compounds; Rats; Rats, Sprague-Dawley; Triazoles; Vasoconstriction; Vasodilation | 1992 |
Endotoxin-induced impairment of vascular reactivity in the pithed rat: role of arachidonic acid metabolites.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Angiotensin II; Animals; Arachidonic Acid; Arachidonic Acids; Blood Pressure; Cyclooxygenase Inhibitors; Dinoprostone; Electric Stimulation; Endotoxins; Epoprostenol; Flurbiprofen; Hemodynamics; Iloprost; Male; Norepinephrine; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred Strains; Spinal Cord; Sympathetic Nervous System | 1990 |
[Effects of the PAF antagonist WEB 2086 on hypoxia and angiotensin II-induced pulmonary vasoconstriction in the isolated perfused rat lung].
Topics: Angiotensin II; Animals; Azepines; Hypoxia; Organ Culture Techniques; Perfusion; Platelet Activating Factor; Pulmonary Circulation; Rats; Triazoles; Vasoconstriction | 1991 |
Role of platelet activating factor in the adhesion process of polymorphonuclear neutrophils to endothelial cells.
Topics: Angiotensin II; Calcimycin; Cell Adhesion; Endothelium, Vascular; Humans; Kinetics; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Platelet Activating Factor; Thrombin | 1991 |
Effect of ambient oxygen changes on platelet activating factor production by fetal ovine endothelial cells.
Topics: Acetates; Angiotensin II; Animals; Blood Platelets; Bradykinin; Cells, Cultured; Endothelium, Vascular; Fetus; Hypoxia; Indomethacin; Ionophores; Oxygen; Platelet Activating Factor; Platelet Aggregation; Rabbits; Serotonin; Sheep | 1991 |
Production of platelet-activating factor is a component of the angiotensin II-protein kinase C activation pathway in bovine adrenocortical cells.
Topics: Acetyltransferases; Adrenal Cortex; Angiotensin II; Animals; Calcium; Cattle; Cell Membrane; Enzyme Activation; Kinetics; Membrane Proteins; Phospholipids; Phosphoproteins; Phosphorylation; Platelet Activating Factor; Protein Kinase C | 1991 |
Release of platelet activating factor by the isolated kidney is not linked to the production of prostaglandins.
Topics: Angiotensin II; Animals; Bradykinin; Calcimycin; Dinoprostone; In Vitro Techniques; Kidney; Male; Perfusion; Platelet Activating Factor; Prostaglandins; Rats; Rats, Inbred Strains; Renal Veins; Stimulation, Chemical; Vascular Resistance | 1991 |
Renal effects and mesangial cell contraction induced by endothelin are mediated by PAF.
Topics: Angiotensin II; Animals; Endothelins; Glomerular Mesangium; In Vitro Techniques; Kidney; Male; Platelet Activating Factor; Rats; Rats, Inbred Strains | 1991 |
Mechanism of increased angiotensin-converting enzyme activity stimulated by platelet-activating factor.
Topics: Angiotensin I; Angiotensin II; Animals; Calcium; Cattle; Cells, Cultured; Endothelium; Neomycin; Peptidyl-Dipeptidase A; Platelet Activating Factor; Pulmonary Artery; Type C Phospholipases | 1990 |
Platelet-activating factor stimulates angiotensin converting enzyme activity.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cattle; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium, Vascular; Peptidyl-Dipeptidase A; Platelet Activating Factor | 1990 |
Insulin-dependent contractility of glomerular mesangial cells in response to angiotensin II, platelet-activating factor and endothelin is attenuated by prostaglandin E2.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenylyl Cyclases; Angiotensin II; Animals; Calcium; Cells, Cultured; Dinoprostone; Endothelins; Glomerular Mesangium; Indomethacin; Insulin; Kidney Cortex; Kinetics; Male; Platelet Activating Factor; Rats; Rats, Inbred Strains | 1990 |
Relationship of GTP-binding proteins, phospholipase C, and PGE2 synthesis in rat glomerular mesangial cells.
Topics: Angiotensin II; Animals; Calcimycin; Dinoprostone; Glomerular Mesangium; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Guanosine Triphosphate; Inositol Phosphates; Platelet Activating Factor; Rats; Thionucleotides; Type C Phospholipases | 1989 |
Angiotensin II causes formation of platelet activating factor in cultured rat mesangial cells.
Topics: Angiotensin II; Animals; Biological Assay; Cells, Cultured; Gas Chromatography-Mass Spectrometry; Glomerular Mesangium; Platelet Activating Factor; Rats | 1989 |
Inhibition of vasoconstriction by platelet activating factor in the in situ blood perfused rat mesentery.
Topics: Angiotensin II; Animals; Blood Pressure; Electric Stimulation; Male; Norepinephrine; Platelet Activating Factor; Prazosin; Quinolinium Compounds; Rats; Rats, Inbred Strains; Serotonin; Splanchnic Circulation; Vasoconstriction | 1989 |
Hypothesis: a central role for platelet activating factor in the pathogenesis of pre-eclampsia.
Topics: Angiotensin II; Female; Humans; Immune Tolerance; Platelet Activating Factor; Pre-Eclampsia; Pregnancy; Thromboxanes | 1989 |
Differential effect of platelet-activating factor (PAF) receptor antagonists on peptide and PAF-stimulated prostaglandin release in unilateral ureteral obstruction.
Topics: Angiotensin II; Animals; Benzofurans; Dinoprostone; Kidney; Lignans; Male; Peptides; Platelet Activating Factor; Platelet Membrane Glycoproteins; Prostaglandins; Prostaglandins E; Rabbits; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Thromboxane B2; Triazolam; Ureteral Obstruction | 1988 |
Atrial natriuretic peptide inhibits glomerular contraction induced by angiotensin II and platelet activating factor.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; In Vitro Techniques; Kidney Glomerulus; Muscle Contraction; Muscle, Smooth; Platelet Activating Factor; Rats; Rats, Inbred Strains | 1987 |
Inhibition and subsequent enhancement of platelet responsiveness by prostacyclin in the rabbit. Relationship to platelet adenosine 3',5'-cyclic monophosphate.
Topics: Adenosine Triphosphate; Angiotensin II; Animals; Blood Platelets; Cyclic AMP; Epoprostenol; Platelet Activating Factor; Platelet Aggregation; Rabbits; Serotonin | 1985 |
PAF antagonists: different effects on platelets, neutrophils, guinea pig ileum and PAF-induced vasodilation in isolated rat lung.
Topics: Alprazolam; Angiotensin II; Animals; Blood Platelets; Dose-Response Relationship, Drug; Guinea Pigs; Ileum; Muscle Contraction; Neutrophils; Phospholipid Ethers; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pulmonary Artery; Pulmonary Circulation; Rabbits; Rats; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Serotonin; SRS-A; Thiazoles; Vasodilation | 1986 |
Different concentrations of pertussis toxin have opposite effects on agonist-induced PGE2 formation in mesangial cells.
Topics: Angiotensin II; Animals; Calcimycin; Cells, Cultured; Dinoprostone; Dose-Response Relationship, Drug; GTP-Binding Proteins; In Vitro Techniques; Kidney Glomerulus; Membrane Proteins; Molecular Weight; NAD; Pertussis Toxin; Platelet Activating Factor; Prostaglandins E; Rats; Virulence Factors, Bordetella | 1986 |
Platelet-activating factor antagonists increase vascular reactivity in perfused rat lungs.
Topics: Angiotensin II; Animals; Furans; Hypoxia; In Vitro Techniques; Male; Perfusion; Platelet Activating Factor; Pulmonary Circulation; Quinolinium Compounds; Rats; Rats, Inbred Strains; Vasoconstriction | 1988 |
Platelet-activating factor-induced homologous and heterologous desensitization in cultured vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Aorta; Benzofurans; Calcium; Cells, Cultured; Cytosol; Diglycerides; Fluorescent Dyes; Fura-2; Inositol 1,4,5-Trisphosphate; Inositol Phosphates; Male; Muscle, Smooth, Vascular; Platelet Activating Factor; Rats; Rats, Inbred Strains; Spectrometry, Fluorescence; Tetradecanoylphorbol Acetate; Vasopressins | 1988 |
L-platelet activating factor induces changes on renal vascular resistance, vascular reactivity, and renin release in the isolated perfused rat kidney.
Topics: Angiotensin II; Animals; Blood Vessels; Dose-Response Relationship, Drug; In Vitro Techniques; Kidney; Male; Norepinephrine; Perfusion; Platelet Activating Factor; Rats; Rats, Inbred Strains; Renal Circulation; Renin; Vascular Resistance; Vasodilation | 1987 |
Effects of platelet-activating factor on conversion of angiotensin I to II.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Cattle; Cell Survival; Cells, Cultured; Endothelium; Platelet Activating Factor; Pulmonary Artery | 1987 |
Hemodynamic effects of PAF-acether.
Topics: Angiotensin II; Animals; Blood Pressure; Dogs; Female; Hemodynamics; Indomethacin; Platelet Activating Factor; Renal Circulation; Saralasin; Sodium | 1986 |
Vasoconstrictor-evoked prostaglandin synthesis in cultured human mesangial cells.
Topics: Angiotensin II; Arginine Vasopressin; Butyrates; Butyric Acid; Calcimycin; Cells, Cultured; Dose-Response Relationship, Drug; Glomerular Mesangium; Humans; Platelet Activating Factor; Prostaglandins; Surface Properties; Time Factors; Vasoconstrictor Agents | 1985 |
Impact of platelet activating factor on vascular responsiveness in isolated rat lungs.
Topics: Angiotensin II; Animals; Cytochalasin B; Dose-Response Relationship, Drug; Lung; Male; Perfusion; Platelet Activating Factor; Potassium Chloride; Pulmonary Artery; Rats; Vasoconstriction; Vasodilation | 1986 |
Evidence for the lack of interaction between (+/-)-1-O-octadecyl-2-acetylglyceryl-3-phosphorylcholine and alpha-adrenoceptors in vivo and in vitro.
Topics: Angiotensin II; Animals; Blood Pressure; Cats; Epinephrine; In Vitro Techniques; Male; Nictitating Membrane; Norepinephrine; Phentolamine; Platelet Activating Factor; Rats; Rats, Inbred SHR; Receptors, Adrenergic, alpha; Splanchnic Circulation | 1984 |
alpha-Adrenergic blocking action of 1-O-hexadecyl-2-O-acetyl-sn-glycero-3-phosphocholine in rats.
Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Male; Mannitol; Norepinephrine; Platelet Activating Factor; Rats; Rats, Inbred Strains | 1983 |
The release of platelet-activating factor from human endothelial cells in culture.
Topics: Angiotensin II; Animals; Calcimycin; Cells, Cultured; Chemical Phenomena; Chemistry, Physical; Endothelium; Factor VIII; Humans; Platelet Activating Factor; Rabbits; Umbilical Veins; Vasopressins | 1983 |
Possible involvement of cyclooxygenase products in the actions of platelet-activating factor and of lipoxygenase products in the vascular effects of epinephrine in perfused rat liver.
Topics: Acetophenones; Angiotensin II; Animals; Epinephrine; Female; Indomethacin; Lipoxygenase; Liver; Liver Glycogen; Perfusion; Platelet Activating Factor; Propranolol; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred Strains; Vasoconstriction | 1984 |
Studies on the interactions of acetyl glycerol ether phosphoryl choline with the sympathetic nervous system in rats.
Topics: Angiotensin II; Animals; Blood Pressure; Heart Rate; Hemodynamics; Hypertension; Male; Phenylephrine; Platelet Activating Factor; Rats; Rats, Inbred Strains; Spinal Cord; Sympatholytics | 1982 |
Effects of phospholipids on renal function.
Topics: Angiotensin II; Animals; Arginine; Diuresis; Dogs; Hemodynamics; Kidney; Lysophosphatidylcholines; Natriuresis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Norepinephrine; Platelet Activating Factor; Rats; Renal Artery; Renal Circulation; Structure-Activity Relationship; Vasodilation; Vasopressins | 1993 |
Effect of platelet activating factor (PAF) on the formation of blood vessels in subcutaneous implants in mice.
Topics: Angiotensin II; Animals; Endothelins; Kinetics; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Platelet Activating Factor; Prostheses and Implants; Xenon Radioisotopes | 1994 |
Insulin nonattenuation of vasoactive agent-induced responses in mesangial cells from spontaneously hypertensive rats.
Topics: Angiotensin II; Animals; Calcium; Cells, Cultured; Endothelins; Glomerular Mesangium; Hypertension; Insulin; Intracellular Fluid; Male; Platelet Activating Factor; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1995 |
Insulin attenuates intracellular calcium responses and cell contraction caused by vasoactive agents.
Topics: Angiotensin II; Animals; Calcium; Cell Size; Cells, Cultured; Dose-Response Relationship, Drug; Endothelins; Fura-2; Glomerular Mesangium; Insulin; Insulin-Like Growth Factor I; Male; Platelet Activating Factor; Rats; Rats, Wistar; Time Factors; Vasoconstrictor Agents | 1994 |
Studies on the metabolism of metallothionein and alkaline phosphatase of adult rat primary hepatocyte cultures: role of fetal calf serum and agonists of the phosphoinositide cascade.
Topics: Alkaline Phosphatase; Angiotensin II; Animals; Arginine Vasopressin; Calcimycin; Cells, Cultured; Culture Media; Dexamethasone; Diglycerides; Liver; Metallothionein; Phosphatidylinositols; Platelet Activating Factor; Rats; Tetradecanoylphorbol Acetate; Zinc | 1993 |
Platelet-activating factor induces selective pulmonary arterial hyperreactivity in isolated perfused rabbit lungs.
Topics: Angiotensin II; Animals; Dinoprost; Female; In Vitro Techniques; Norepinephrine; Perfusion; Platelet Activating Factor; Potassium Chloride; Pulmonary Artery; Pulmonary Circulation; Rabbits; Regression Analysis; Time Factors; Vascular Resistance | 1993 |
Nitric oxide mediates the inhibitory action of platelet-activating factor on angiotensin II-induced renal vasoconstriction, in vivo.
Topics: Angiotensin II; Animals; Arginine; Blood Pressure; Enzyme Inhibitors; Kidney; Linear Models; Male; Nitric Oxide; omega-N-Methylarginine; Platelet Activating Factor; Rats; Rats, Wistar; Vasoconstriction | 1996 |
Renal effect of YM435, a new dopamine D1 receptor agonist, in anesthetized dogs.
Topics: Anesthesia; Angiotensin II; Animals; Benzazepines; Dogs; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Electric Stimulation; Female; Hemodynamics; Infusions, Intravenous; Isoquinolines; Kidney; Kidney Diseases; Kidney Function Tests; Male; Platelet Activating Factor; Receptors, Dopamine D1; Renal Circulation; Tetrahydroisoquinolines; Vasodilator Agents | 1997 |
Platelet-activating factor mediates angiotensin II-induced proteinuria in isolated perfused rat kidney.
Topics: Angiotensin II; Animals; Azepines; Dexamethasone; Glucocorticoids; In Vitro Techniques; Kidney; Male; Perfusion; Platelet Activating Factor; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Proteinuria; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Triazoles | 1997 |
Platelet-activating factor modulates pulmonary vasomotor tone in the perinatal lamb.
Topics: Angiotensin II; Animals; Animals, Newborn; Azepines; Blood Pressure; Female; Muscle Tonus; Muscle, Smooth, Vascular; Platelet Activating Factor; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Pregnancy; Pulmonary Circulation; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Sheep; Triazoles; Vascular Resistance; Vasoconstrictor Agents | 1998 |
Interleukin-12 is synthesized by mesangial cells and stimulates platelet-activating factor synthesis, cytoskeletal reorganization, and cell shape change.
Topics: Angiotensin II; Azepines; Cell Size; Cells, Cultured; Cytoskeleton; Dose-Response Relationship, Drug; Glomerular Mesangium; Humans; Interleukin-12; Interleukin-8; Lipopolysaccharides; Platelet Activating Factor; Platelet Aggregation Inhibitors; Receptors, Interleukin; Receptors, Interleukin-12; RNA, Messenger; Superoxides; Time Factors; Triazoles; Tumor Necrosis Factor-alpha | 1999 |
Reactive oxygen species mediate angiotensin II-induced leukocyte-endothelial cell interactions in vivo.
Topics: Angiotensin II; Animals; Catalase; Cell Adhesion; Cell Communication; Chemotaxis, Leukocyte; Endothelium, Vascular; Kinetics; Leukocytes; Leukotriene Antagonists; Leukotrienes; Male; Microcirculation; Microscopy, Video; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Splanchnic Circulation; Superoxide Dismutase | 2001 |
Microvascular reactivity in experimental diabetes: responses of male and female rats.
Topics: Acetylcholine; Angiotensin II; Animals; Body Weight; Bradykinin; Diabetes Mellitus, Experimental; Estrous Cycle; Female; Histamine; Hypoglycemic Agents; Insulin; Male; Microcirculation; Nitroprusside; Norepinephrine; Organ Size; Platelet Activating Factor; Rats; Rats, Wistar; Sex Characteristics; Uterus; Vasoconstrictor Agents; Vasodilator Agents | 2003 |
Effect of boldine, secoboldine, and boldine methine on angiotensin II-induced neutrophil recruitment in vivo.
Topics: Angiotensin II; Animals; Aporphines; Chemokine CXCL2; Chemokines; Chemokines, CXC; Endothelial Cells; Humans; Infusions, Parenteral; Intercellular Signaling Peptides and Proteins; Interleukin-8; Keratinocytes; Male; Molecular Structure; Monokines; Neutrophils; P-Selectin; Phenanthrenes; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species | 2005 |
Angiotensin II effect on hydraulic permeability: interaction with endothelin-1, nitric oxide, and platelet activating factor.
Topics: Angiotensin II; Animals; Capillary Permeability; Drug Interactions; Endothelin A Receptor Antagonists; Endothelin-1; Endothelium, Vascular; Female; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oligopeptides; Platelet Activating Factor; Rats; Rats, Sprague-Dawley | 2006 |